These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25575135)

  • 1. Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.
    Postupna N; Keene CD; Crane PK; Gonzalez-Cuyar LF; Sonnen JA; Hewitt J; Rice S; Howard K; Montine KS; Larson EB; Montine TJ
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):100-9. PubMed ID: 25575135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of APOE with tau-tangle pathology with and without β-amyloid.
    Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA
    Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex.
    Flanagan ME; Larson EB; Walker RL; Keene CD; Postupna N; Cholerton B; Sonnen JA; Dublin S; Crane PK; Montine TJ
    J Alzheimers Dis; 2018; 61(2):653-662. PubMed ID: 29226863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
    Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
    JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
    Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
    Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans.
    DeKosky ST; Abrahamson EE; Ciallella JR; Paljug WR; Wisniewski SR; Clark RS; Ikonomovic MD
    Arch Neurol; 2007 Apr; 64(4):541-4. PubMed ID: 17420316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.
    Friedberg JS; Aytan N; Cherry JD; Xia W; Standring OJ; Alvarez VE; Nicks R; Svirsky S; Meng G; Jun G; Ryu H; Au R; Stein TD
    Sci Rep; 2020 Feb; 10(1):2924. PubMed ID: 32076055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different patterns of cerebral injury in dementia with or without diabetes.
    Sonnen JA; Larson EB; Brickell K; Crane PK; Woltjer R; Montine TJ; Craft S
    Arch Neurol; 2009 Mar; 66(3):315-22. PubMed ID: 19139294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.
    Herukka SK; Helisalmi S; Hallikainen M; Tervo S; Soininen H; Pirttilä T
    Neurobiol Aging; 2007 Apr; 28(4):507-14. PubMed ID: 16546302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
    Strong C; Anderton BH; Perry RH; Perry EK; Ince PG; Lovestone S
    Alzheimer Dis Assoc Disord; 1995; 9(4):218-22. PubMed ID: 8749611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
    Kester MI; Verwey NA; van Elk EJ; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2011 Aug; 32(8):1372-8. PubMed ID: 19748159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.